Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-01-05 Sale |
2021-01-06 7:15 pm |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
35,000 | $0.9 | $31,500 | 104,789 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-16 Option Award |
2025-01-21 5:17 pm |
N/A 2035-01-16 |
HeartSciences Inc. | HSCS | Wells David R. Director |
6,000 | $0 | 6,000 (Direct) |
View |
2023-10-15 Option Award |
2023-10-17 4:09 pm |
N/A 2033-10-15 |
Envoy Medical Inc. | COCH | Wells David R. Chief Financial Officer |
293,250 | $0 | 293,250 (Direct) |
View |
2023-03-20 Option Award |
2023-03-22 7:56 pm |
N/A 2033-03-20 |
Heart Test Laboratories Inc. | HSCS | Wells David R. Director |
50,000 | $0 | 50,000 (Direct) |
View |
2021-04-05 Option Award |
2021-04-07 4:10 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
25,000 | $0 | 25,000 (Direct) |
View |
2020-06-23 Exercise |
2020-06-24 08:22 am |
2019-12-11 2024-12-11 |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
5,000 | $0 | 144,840 (Direct) |
View |
2020-06-23 Exercise |
2020-06-24 08:22 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
5,000 | $0.87 | 144,840 (Direct) |
View |
2020-06-08 Conversion |
2020-06-10 07:38 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
10,350 | $0.87 | 134,789 (Direct) |
View |
2020-06-08 Conversion |
2020-06-10 07:38 am |
2019-12-11 N/A |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
9 | $1,144 | 134,789 (Direct) |
View |